14 Haziran 2021 Pazartesi

Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine


By BY CARL ZIMMER from NYT Health The company’s large U.S. trial found an efficacy rate of about 90 percent. But at this point, the nation is awash in other shots. https://ift.tt/2U8zjPD

Hiç yorum yok:

Yorum Gönder

Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic

By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...